Apr 3, 2019

Israeli Company’s New Cutting-Edge Cancer Treatment

Posted by in categories: biotech/medical, evolution

DAILY DOSE | A new cutting-edge cancer treatment has been developed in one of the innovation capitals of the world — Israel. How does it work and why is some of the medical community eagerly awaiting to use it? Accelerated Evolution Biotechnologies CEO Ilan Morad discusses with host Ayman Sikseck.


Has a cure for cancer finally been found? Maybe, and it may have born right here in Israel.

An Israeli team of scientists is developing an anti-cancer drug that will target several mutations in cancer cells using a combination of several-cancer directed peptides.

The treatment is called MuTaTo, or multi-objective toxin, and is essentially on the scale of a cancer antibiotic.

For more, see our ⬇.

Read more

Comments are closed.